Cargando…

Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells

Background: We aimed to evaluate the expression of cysteine rich 61 (Cyr61) in patients with pulmonary arterial hypertension (PAH) as well as monocrotaline (MCT) induced PAH rat, and further investigate the effects and potential mechanisms of Cyr61 on the proliferation of pulmonary arterial smooth m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Lan, Fan, Yong, Hao, Yanjie, Yuan, Ping, Liu, Dong, Jing, Zhicheng, Zhang, Zhuoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562189/ https://www.ncbi.nlm.nih.gov/pubmed/28824319 http://dx.doi.org/10.7150/ijms.19282

Ejemplares similares

Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis
por: Fan, Yong, et al.
Publicado: (2019)

The Roles of CCN1/CYR61 in Pulmonary Diseases
por: Zhu, Yin, et al.
Publicado: (2020)

Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study
por: Ac\ˇkar, Lucija, et al.
Publicado: (2021)

Expression of Cyr61 in ApoE(−/−) mice with chronic unilateral renal artery ligation
por: Pathak, Alokkumar S., et al.
Publicado: (2021)

Cyr61 Mediates Angiotensin II-Induced Podocyte Apoptosis via the Upregulation of TXNIP
por: Ma, Jingxue, et al.
Publicado: (2023)

Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes
por: Feng, Bin, et al.
Publicado: (2020)

Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
por: Zhang, Fengli, et al.
Publicado: (2018)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Chen, Yong-Jie, et al.
Publicado: (2021)

INCREASED VASCULARITY AND SPONTANEOUS METASTASIS OF BREAST CANCER BY HEDGEHOG SIGNALING MEDIATED UPREGULATION OF CYR61
por: Harris, Lillianne G., et al.
Publicado: (2011)

IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
por: Sarkissyan, Suren, et al.
Publicado: (2014)

Cyr61 Expression is associated with prognosis in patients with colorectal cancer
por: Jeong, Dongjun, et al.
Publicado: (2014)

Cyr61: a potential therapeutic target for prostate cancer
por: Lin, Chang-Ming, et al.
Publicado: (2014)

STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis
por: Chai, Ke-Xia, et al.
Publicado: (2018)

Aberrant activation of CYR61 enhancers in colorectal cancer development
por: Xie, Lingzhu, et al.
Publicado: (2019)

Cyr61/CCN1 targets for chemosensitization in pancreatic cancer
por: Banerjee, Snigdha, et al.
Publicado: (2019)

Retracted: Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
por: Zhang, Fengli, et al.
Publicado: (2021)

ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression
por: Chen, Cong, et al.
Publicado: (2018)

Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2023)

Serum CYR61 Is Associated With Airway Inflammation and Is a Potential Biomarker for Severity in Chronic Obstructive Pulmonary Disease
por: Tan, Zhu-Xia, et al.
Publicado: (2021)

Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
por: Sun, Z-J, et al.
Publicado: (2008)

The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts
por: Todorovicç, Viktor, et al.
Publicado: (2005)

The profile of Cyr61 expression data correlate to the skin inflammation in psoriasis
por: Wu, Pinru, et al.
Publicado: (2016)

Cyr61 Promotes Inflammation of a Gouty Arthritis Model in Rats
por: Zhou, Mi, et al.
Publicado: (2020)

Expression of Cyr61 is associated with clinical course in patients with Crohn’s disease
por: Lee, Su-Mi, et al.
Publicado: (2021)

Corrigendum: Serum CYR61 is associated with airway inflammation and is a potential biomarker for severity in chronic obstructive pulmonary disease
por: Tan, Zhu-Xia, et al.
Publicado: (2023)

Cyr61 promotes Schwann cell proliferation and migration via αvβ3 integrin
por: Cheng, Zhenghui, et al.
Publicado: (2021)

CYR61 as a potential biomarker for the preoperative identification of muscle-invasive bladder cancers
por: Chen, Huang, et al.
Publicado: (2021)

Cyr61 as mediator of Src signaling in triple negative breast cancer cells
por: Sánchez-Bailón, María Pilar, et al.
Publicado: (2015)

Matricellular proteins of the Cyr61/CTGF/NOV (CCN) family and the nervous system
por: Malik, Anna R., et al.
Publicado: (2015)

CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma
por: Wei, Jing, et al.
Publicado: (2016)

Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
por: Chu, Ling-Yu, et al.
Publicado: (2021)

CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett’s Esophagus Malignant Progression
por: Cardoso, Joana, et al.
Publicado: (2016)

Expression of Cyr61, CTGF, and WISP-1 Correlates with Clinical Features of Lung Cancer
por: Chen, Ping-Ping, et al.
Publicado: (2007)

A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis
por: Planque, Nathalie, et al.
Publicado: (2003)

Cyr61, a marker of progesterone activity in normal and hyperplasic endometrium of female dogs
por: Voorwald, Fabiana A, et al.
Publicado: (2013)

Potential Role of Cyr61 Induced Degeneration of Human Müller Cells in Diabetic Retinopathy
por: Zhou, Fen, et al.
Publicado: (2014)

CYR61/CCN1: A novel mediator of epidermal hyperplasia and inflammation in psoriasis?
por: Quan, Taihao, et al.
Publicado: (2015)

CYR61—An angiogenic biomarker to early predict the impaired healing in diaphyseal tibial fractures
por: Ali, Sabir, et al.
Publicado: (2017)

Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion
por: Hellinger, Johanna W., et al.
Publicado: (2019)

Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway
por: Kim, Inho, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eu51ng1n2l189q2fo32i2r087g